
Sep 21, 2026 · 2h 28m
Listen from 36:02
Listen at 36:02
Gut biology reshapes the fight against obesity
Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
The episode connects everyday digestive health with cancer prevention, metabolic disease, weight-loss treatment, and emerging medical technologies.
- 1Fiber, fermented foods, and intestinal barrier function link the microbiome to inflammation and metabolic health.
- 2GLP-1 drugs can change obesity treatment, but side effects, adherence, muscle preservation, and biology still complicate outcomes.
- 3Earlier metabolic testing and increasingly precise procedures may detect or treat disease before conventional diabetes markers appear.
Don't miss
Thompson outlines an experimental gene therapy intended to make pancreatic cells produce GLP-1 alongside insulin in response to nutrients.
The brief
Dr. Chris Thompson explains how the digestive tract acts as an endocrine and immune system, linking mucus, tight junctions, hormones, and the microbiome to whole-body health.
The practical foundation is familiar but consequential: adequate fiber, resistant starch, fermented foods, exercise, screening, and earlier metabolic testing can reveal problems before diabetes is obvious.
GLP-1 medications have transformed obesity care, yet nausea, dose escalation, adherence, muscle loss, and the body’s defended weight set point limit what drugs can accomplish alone.
Thompson describes a medical frontier spanning endoscopic procedures, AI-assisted surgery, capsule imaging, targeted intestinal therapies, and a gene therapy designed to produce nutrient-responsive GLP-1.
The episode’s central tension is whether medicine can intervene earlier and more precisely without outrunning evidence, training, regulation, or the biological complexity of obesity.
What was said on this episode
117 statements · 72 positive · 31 negative · 5 mixed · 9 neutral
Insufficient fiber causes microbes to consume the intestinal mucus layer.
“if you're not feeding them fiber, they'll eat your mucus layer”
Listen at 0:12
“Everyone should start getting screened, uh, make sure, you know, they don't have cancer.”
Listen at 8:56
Colon-cancer screening programs improve survival rates.
“The survival rates are definitely improving due to screening programs”
Listen at 9:33
Colon cancer screening programs improve survival rates.
“The survival rates are definitely improving due to screening programs, right?”
Listen at 9:33
Starting colon-cancer screening at 45 is better than starting at 50.
“starting at 45 is better than many people who started at 50”
Listen at 9:42
People with a family history should start screening at age 40.
“if you have a family member that has had cancer, you want to start at 40”
Listen at 9:48
Zenker’s diverticula should be medically evaluated seriously.
“it is something that should probably be taken seriously and looked at”
Listen at 16:02
Healthy bowel frequency is no more than three daily and no more than three days apart.
“you don't want to have more than 3 a day, and you don't want to go longer than 3 days without having a bowel movement”
Listen at 17:11
Resistant starch supplementation improves fatty liver.
“when they did that, they actually saw a significant improvement in fatty liver”
Listen at 19:12
RS2 resistant starch significantly improves fatty liver.
“they actually saw a significant improvement in fatty liver”
Listen at 19:13
RS2 resistant starch improves insulin resistance and insulin sensitivity.
“they were able to improve insulin resistance and insulin sensitivity as well”
Listen at 19:42
RS2 resistant starch improves insulin resistance and insulin sensitivity.
“they were able to improve insulin resistance and insulin sensitivity as well”
Listen at 19:42
Low fiber intake is associated with poorer microbiome health and diversity.
“if you don't have a lot of fiber, your microbiome's not healthy”
Listen at 19:57
Time-restricted eating benefits outweigh potential microbiome risks.
“the benefit of, of, of the, the time-restricted eating definitely outweighs that, that potential risk”
Listen at 23:03
Time-restricted eating benefits outweigh its potential microbiome risk.
“the benefit of, of, of the, the time-restricted eating definitely outweighs that, that potential risk”
Listen at 23:03
Fermented foods increase microbiome diversity and reduce inflammatory markers.
“with the fermented foods, you had, uh, reclaimed some diversity in, in the microbiome”
Listen at 24:22
Fermented foods increase microbiome diversity and reduce inflammatory markers.
“with the fermented foods, you had, uh, reclaimed some diversity in, in the microbiome, which was great, as well as the reduced inflammatory markers”
Listen at 24:22
Fermented foods benefit gut health through prebiotic and probiotic effects.
“they're beneficial for a variety of reasons”
Listen at 24:43
People should consume fermented foods such as kefir, kimchi, and yogurt.
“I think it's, it's important to, to, to, to recommend that the folks do”
Listen at 27:07
People should consume fermented foods such as kefir, kimchi, and yogurt.
“I think it's, it's important to, to, to, to recommend that the folks do”
Listen at 27:07
Stress can increase gastric acid production and contribute to ulcers.
“if you're stressed, you can produce more acid”
Listen at 29:56
Stress can increase gastric acid production and contribute to ulcers.
“if you're stressed, you can produce more acid”
Listen at 29:56
GLP-1 medications are highly beneficial for treating obesity-related metabolic problems.
“GLP-1s are fantastic from that standpoint”
Listen at 31:10
GLP-1 medications are beneficial for obesity but have limitations.
“GLP-1s are fantastic from that standpoint. They're not perfect, you know, there's limitations”
Listen at 31:10
About 30% discontinue GLP-1 medications within one month and 50% within one year.
“About 30% come off GLP-1s in the first month and then 50% or so by, by the end of the year”
Listen at 31:30
GLP-1 medications can cause nausea and muscle loss.
“nausea is an issue with some of these, you know, muscle loss is an issue”
Listen at 32:22
Stopping GLP-1 medications can cause problems, including weight regain.
“for maintenance, rather than just stopping it— because if you stop the GLP-1, GLP-1s, there's problems”
Listen at 35:34
Stopping GLP-1 medications creates weight-maintenance problems.
“for maintenance, rather than just stopping it— because if you stop the GLP-1, GLP-1s, there's problems, right?”
Listen at 35:34
GLP-1 medications generally need to be continued lifelong to maintain benefits.
“these are kind of lifelong medicines”
Listen at 35:41
GLP-1 medications are generally intended as lifelong treatments.
“These are kind of lifelong medicines.”
Listen at 35:41
Approximately one-third of GLP-1-associated weight loss is lean mass.
“when you lose weight, about a third of the weight you lose would be lean mass”
Listen at 36:02
Approximately one-third of semaglutide-associated weight loss is lean mass.
“when you lose weight, about a third of the weight you lose would be lean mass”
Listen at 36:02
Cycling GLP-1 medications can worsen body composition by restoring fat rather than lean mass.
“when you cycle on and off, right? So say you come off of it and you put your weight back on, you're not putting the lean mass back on, okay? You're putting the fat back on.”
Listen at 36:10
People discontinuing GLP-1 medications should use microdosing or a bridging plan.
“If you're coming off the GLP-1, you need either to microdose it or have a bridging plan”
Listen at 36:37
Resistance training helps preserve muscle during weight loss.
“resistance training, definitely”
Listen at 36:56
Resistance training helps preserve muscle during weight loss.
“resistance training, definitely”
Listen at 36:56
Muscle loss is a major reason patients discontinue GLP-1 medications.
“muscle loss honestly is, is one of the bigger ones”
Listen at 38:43
Patients at risk of muscle loss should obtain a DEXA scan before GLP-1 treatment.
“it's good to get a DEXA scan beforehand”
Listen at 39:09
Bariatric procedures work through mechanisms beyond restriction or calorie malabsorption.
“they work entirely different than what they thought”
Listen at 42:53
Compassionate-use pathways allow expedited access to unapproved treatments.
“there are compassionate use cases where you need to make exceptions, and then they have expedited protocols for that”
Listen at 44:28
GIP activity may reduce nausea from higher GLP-1 doses.
“It does help. I think it helps with nausea”
Listen at 50:37
GIP may reduce nausea, improve insulin sensitivity, and act synergistically with GLP-1.
“GIP, I think, plays that role. It has a role in insulin sensitivity as well, and it does some of the same stuff GLP-1 does, and it's synergistic, I think.”
Listen at 50:44
Glucagon may help preserve muscle in combination obesity therapies.
“glucagon is potential muscle sparing there”
Listen at 50:54
Glucagon activity in retatrutide may preserve muscle during weight loss.
“glucagon is potential muscle sparing there”
Listen at 50:54
Processed-food diets cause people to consume roughly 500 additional daily calories.
“the people that were eating the processed foods, they could eat at will, they're eating like 500 calories more a day”
Listen at 53:13
Leptin-based obesity drugs failed largely because obesity causes leptin resistance.
“leptin never panned out in large part because of leptin resistance”
Listen at 55:05
Leptin-based obesity treatments failed largely because of leptin resistance.
“leptin never panned out in large part because of leptin resistance”
Listen at 55:05
Diagnostic technology should become less invasive and easier to scale.
“I would love to see innovation and technology go where we have minimally invasive ways of diagnosing things”
Listen at 1:07:17
Meal glucose spikes to 200 indicate sensitivity to those foods.
“if your glucose is shooting up to 200 with certain meals, You know you're sensitive to that”
Listen at 1:08:27
High fasting insulin predicts greater long-term diabetes risk.
“if someone had high fasting insulin, they're more likely to get diabetes long-term”
Listen at 1:08:59
High fasting insulin predicts greater long-term diabetes risk.
“if someone had high fasting insulin, they're more likely to get diabetes long-term”
Listen at 1:08:59
People should use CGMs briefly to identify glucose-spiking foods and adjust diet.
“Get one for for a month or two, learn what spikes your glucose, see if something spikes your glucose and adjust it.”
Listen at 1:09:53
A fasting glucose-insulin index above two indicates insulin resistance.
“if it's greater than 2, you have insulin resistance”
Listen at 1:13:11
Loss of metabolic flexibility increases risk of weight gain and obesity.
“once you have a loss of metabolic flexibility, they've shown in studies that you're more likely to gain weight and develop obesity”
Listen at 1:14:01
A respiratory exchange ratio near 0.7 indicates predominant fat burning.
“if that ratio is like 0.7, uh, so it's, it's volume of carbon dioxide over oxygen, that means you're using more oxygen. That means you're burning fats”
Listen at 1:15:08
A respiratory exchange ratio near 0.7 indicates predominant fat burning.
“if that ratio is like 0.7, uh, so it's, it's volume of carbon dioxide over oxygen, that means you're using more oxygen. That means you're burning fats”
Listen at 1:15:08
Early metabolic intervention produces better treatment outcomes than delayed intervention.
“if you don't act early, you're much less likely to have a good treatment effect”
Listen at 1:20:45
Delaying metabolic treatment reduces the likelihood of a good outcome.
“if you don't act early, you're much less likely to have a good treatment effect”
Listen at 1:20:45
CGM data can help patients modify eating to reduce insulin spikes.
“you need the CGM to learn how to eat”
Listen at 1:21:18
CGM-guided dietary changes can help prevent insulin spikes.
“you got to learn how to eat to not spike your insulin”
Listen at 1:21:31
More diagnostic information is generally better, provided follow-up risks are managed.
“more information is better almost in all circumstances with diagnostic stuff”
Listen at 1:23:05
More diagnostic information is generally beneficial despite interpretation risks.
“more information is better almost in all circumstances with diagnostic stuff”
Listen at 1:23:05
AI can coach clinicians during endoscopic procedures.
“AI starting to have an impact where it can actually coach you through procedures”
Listen at 1:26:50
Real-time surgical AI can guide anatomy recognition and stitch placement.
“It can actually highlight certain structures you want to work on. It can actually point to something where you want to put your stitch, right? And it can count the stitches as you're placing them and tell you if they're close enough together.”
Listen at 1:27:04
Robotic systems can dramatically shorten trainees’ learning curve for complex procedures.
“they will struggle horribly with the original way. That's why it takes 2 or 3 years to learn how to do it. They'll sit down on the robot and be almost good as an expert.”
Listen at 1:28:09
Robotic assistance can make trainees nearly as effective as experts on complex procedures.
“they'll sit down on the robot and be almost good as an expert”
Listen at 1:28:13
Exceptional surgeons may outperform robots when operating without robotic assistance.
“a truly exceptional surgeon is probably just gonna be better without the robot”
Listen at 1:29:18
Patients should consider a surgeon’s procedure volume when choosing care.
“if you're having a procedure, you want to know volume, because volume is important”
Listen at 1:30:01
Patients should consider a surgeon’s procedure volume when choosing a physician.
“if you're having a procedure, you want to know volume, because volume is important”
Listen at 1:30:01
AI visualization can identify vessels and reduce bleeding risk during endoscopic procedures.
“AI can actually see those vessels because it's got pattern recognition and color them for you so you don't hit the vessels as you go, reducing your chances of hitting a blood vessel”
Listen at 1:35:00
AI guidance can identify vessels during endoscopy and reduce bleeding risk.
“AI can actually see those vessels because it's got pattern recognition and color them for you so you don't hit the vessels as you go, reducing your chances of hitting a blood vessel”
Listen at 1:35:00
Hyperspectral imaging can distinguish tissues through tissue-specific optical fingerprints.
“each tissue actually has a fingerprint”
Listen at 1:36:37
Hyperspectral imaging can identify tissue signatures and tumor margins without dyes.
“each tissue actually has a fingerprint. So you can actually use this, this hyperspectral imaging to fingerprint tissue, and you can actually see margins of tumors with this”
Listen at 1:36:37
Hyperspectral imaging can reveal tumor margins without dyes.
“you can actually see margins of tumors with this”
Listen at 1:36:43
Comprehensive noninvasive disease scanning remains uncertain but possible.
“I don't know if we'll get there. I'm hoping, right?”
Listen at 1:40:29
Physiological GLP-1 is nutrient-responsive and secreted by intestinal L cells.
“Our GLP-1 is secreted, it's nutrient responsive, it's secreted from L cells”
Listen at 1:41:47
Targeted gastrointestinal therapies can produce better outcomes than nonspecific devices.
“we can actually develop targeted therapies. And I think that's what's very exciting. It's more so even than, than a new device. It's being able to do targeted therapies and get better outcomes with that.”
Listen at 1:42:26
Closing gastric bypass fistulas resolved diabetes in 60% of treated patients.
“where we closed the fistulas, 60% of people had resolution of their diabetes”
Listen at 1:46:56
Duodenal ablation can reduce A1C by more than one point.
“your A1C drops by over a point”
Listen at 1:50:37
Duodenal ablation reduces hemoglobin A1C by more than one point.
“your A1C drops by over a point”
Listen at 1:50:37
Duodenal ablation may prevent weight regain after GLP-1 discontinuation.
“when someone comes off a GLP-1, if you use this treatment, it keeps them from regaining their weight”
Listen at 1:50:50
Obesity and type 2 diabetes are associated with longer, thicker, more inflamed intestinal tissue.
“the villi are longer, it's thicker, there's more inflammation in people with obesity or type 2 diabetes”
Listen at 1:51:51
Increased intestinal permeability is a real physiological condition.
“increased gut permeability is 100% real”
Listen at 1:54:07
Increased intestinal permeability is a real physiological condition.
“increased gut permeability is 100% real”
Listen at 1:54:07
Increased gut permeability is linked to metabolic illness.
“it is actually tied to metabolic illness”
Listen at 1:55:11
MASH is associated with less-developed and disorganized intestinal tight junctions.
“the tight junctions were far less well-developed and more disorganized in the MASH patients compared to the control patients”
Listen at 1:55:48
Bacterial lipopolysaccharide crossing gut junctions triggers inflammatory problems.
“if that gets through these tight junctions, it causes all sorts of problems”
Listen at 1:57:31
Injected LPS induces insulin resistance in healthy people.
“they found it induced insulin resistance”
Listen at 1:58:04
A healthy microbiome and butyrate support healthy intestinal epithelial cells.
“that microbiome and that butyrate is critical to producing healthy enterocytes”
Listen at 1:58:18
Artificial sweeteners are preferable to high-fructose corn syrup.
“I think they're better than high fructose corn syrup for sure”
Listen at 2:00:21
Artificial sweeteners are preferable to high-fructose corn syrup.
“I think they're better than high fructose corn syrup for sure”
Listen at 2:00:21
Polyunsaturated fats reduce LDL cholesterol and provide health benefits.
“the polyunsaturated fat has been shown to reduce LDL and has, has health benefits”
Listen at 2:01:37
Olive oil is preferable, with butter consumed only in small amounts.
“olive oil is the best, obviously, then small amounts of butter”
Listen at 2:02:51
Olive oil is preferred, with butter consumed only in small amounts.
“olive oil is the best, obviously, then small amounts of butter”
Listen at 2:02:51
People should avoid consuming oxidized oils.
“You don't want to take an oxidized oil into your body”
Listen at 2:03:12
People should avoid consuming oxidized oils.
“you don't want to take an oxidized oil into your body”
Listen at 2:03:12
Nutritional supplements should target documented deficiencies rather than be universal.
“Universally supplementing is not necessarily the way to go. You want to find a deficit and then supplement”
Listen at 2:04:05
People should supplement omega-3s when a nutritional deficit exists.
“You want to find a deficit and then supplement”
Listen at 2:04:08
Patients losing weight should perform HIIT, Zone 2 cardio, and resistance training.
“I try to have them do those things: HIIT, little zone 2, and then resistance training”
Listen at 2:06:22
Patients losing weight should combine HIIT, Zone 2 cardio, and resistance training.
“I try to have them do those things: HIIT, little zone 2, and then resistance training. I think those are the most important things long term.”
Listen at 2:06:22
Rapid Biggest Loser-style weight loss can reduce daily energy expenditure by about 500 calories.
“The Biggest Loser was a great— there was that kind of an NIH follow-up study to that, and they found that they were burning 500 fewer calories per day after that.”
Listen at 2:08:06
The Biggest Loser participants burned about 500 fewer calories daily after weight loss.
“they found that they were burning 500 fewer calories per day after that”
Listen at 2:08:09
Adding ghrelin-cell ablation may raise endoscopic weight loss from 18% to roughly 25%.
“the weight loss goes from about 18% with DSG alone in a top center, goes up to way over 20%, maybe 25% if you start ablating the ghrelin— the ghrelin-producing cells”
Listen at 2:10:19
Adding ghrelin-cell ablation may increase ESG weight loss from 18% to roughly 25%.
“the weight loss goes from about 18% with DSG alone in a top center, goes up to way over 20%, maybe 25% if you start ablating the ghrelin— the ghrelin-producing cells”
Listen at 2:10:19
Jejunoileal anastomosis produces large GLP-1 spikes.
“what we found is you get these big spikes in GLP-1”
Listen at 2:11:55
Magnetic jejunum–ileum anastomosis produces large GLP-1 spikes.
“you get these big spikes in GLP-1”
Listen at 2:11:56
Multimodal treatments may reduce risks by distributing effects across biological pathways.
“you can mitigate risk by doing that, by not giving too much of one thing”
Listen at 2:14:07
Multimodal obesity treatment can mitigate risks of excessive single-pathway dosing.
“you can mitigate risk by doing that, by not giving too much of one thing”
Listen at 2:14:07
Diet and exercise alone often fail to sustain weight loss because of defended weight set points.
“diet and exercise alone don't work because of the set point”
Listen at 2:15:46
An experimental viral-vector therapy delivers a GLP-1 gene to pancreatic cells.
“they've developed a viral vector, right, that has the gene for GLP-1 in it”
Listen at 2:17:38
Beta-cell gene therapy could make insulin secretion simultaneously produce GLP-1.
“when a patient would, uh, secrete insulin in a nutrient-responsive way, they'd simultaneously be secreting GLP-1”
Listen at 2:17:51
The gene therapy aims to make pancreatic beta cells secrete GLP-1 alongside insulin responsively.
“when a patient would, uh, secrete insulin in a nutrient-responsive way, they'd simultaneously be secreting GLP-1”
Listen at 2:17:51
The proposed pancreatic gene therapy may provide permanent episomal GLP-1 expression.
“it's a, it's a permanent— the episomal DNA stays in there”
Listen at 2:20:11
A one-time GLP-1 gene-therapy injection could provide a useful treatment option.
“So one-time GLP-1 injection, that could be nice”
Listen at 2:20:56
A one-time GLP-1 gene therapy injection could provide lasting treatment benefits.
“one-time GLP-1 injection, that could be nice”
Listen at 2:20:56
In diabetic mice, GLP-1 transgene therapy produced slightly greater weight loss than semaglutide.
“both groups lose weight. Transgene loses a little more”
Listen at 2:21:51
In mice, GLP-1 transgene therapy produces slightly greater weight loss than semaglutide.
“both groups lose weight. Transgene loses a little more”
Listen at 2:21:51
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.